Dr Marina Klein (McGill University Health Centre, Montreal, Canada) joins touchINFECTIOUS DISEASES to discuss triple elimination of three infections (HIV, HBV and HCV) prevalent in low- and middle-income countries. Dr Klein highlights the challenges of transmission of HIV, hepatitis B and hepatitis C. She also looks current therapies for HIV, the elimination of Hepatitis C, and the challenges that surround treatment of hepatitis B.
The presentation entitled ‘Triple elimination: HIV, HCV, HBV’ was presented at the International AIDS Society (IAS) 29 July – 2 August, 2022.
Questions:
- What are the available treatments for HIV, HBV and HCV? (0:14)
- What clinical evidence is available for these treatments? (1:57)
Disclosures: Marina Klein is a consultant for Gilead Science; receives grant/research support from Abbvie, Gilead Sciences, and ViiV Healthcare; and is on the advisory board for Abbvie, and ViiV Healthcare.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Shanice Allen.
